Combination metformin and rosiglitazone therapy: Mechanism of glucose lowering in newly diagnosed type 2 diabetes

被引：0
作者：
Triplitt, C
Cersosimo, E
Miyazaki, Y
Glass, L
Wajcberg, E
Mandarino, L
DeFronzo, R
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A144 / A144
页数：1
相关论文
共 50 条
[31]   Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetes [J].
Mor, A. ;
Berencsi, K. ;
Svensson, E. ;
Rungby, J. ;
Nielsen, J. S. ;
Friborg, S. ;
Brandslund, I. ;
Christiansen, J. S. ;
Vaag, A. ;
Beck-Nielsen, H. ;
Sorensen, H. T. ;
Thomsen, R. W. .
DIABETIC MEDICINE, 2015, 32 (12) :1546-1554
[32]   Repaglinide in combination therapy with metformin in Type 2 diabetes [J].
Moses, R .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 :S136-S139
[33]   Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes [J].
Yilmaz, Hamiyet ;
Gursoy, Alptekin ;
Sahin, Mustafa ;
Demirag, Nilgun Guvener .
ACTA DIABETOLOGICA, 2007, 44 (04) :187-192
[34]   Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes [J].
Hamiyet Yilmaz ;
Alptekin Gursoy ;
Mustafa Sahin ;
Nilgun Guvener Demirag .
Acta Diabetologica, 2007, 44 :187-192
[35]   Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach [J].
Cersosimo, Eugenio ;
Johnson, Eric L. ;
Chovanes, Christina ;
Skolnik, Neil .
DIABETES OBESITY & METABOLISM, 2018, 20 (03) :497-507
[36]   Mechanisms of improved glucose metabolism with combination metformin and rosiglitazone therapy. [J].
Triplitt, CL ;
Cersosimo, E ;
Miyazaki, Y ;
Glass, L ;
Wajcberg, E ;
De Filippis, E ;
Cusi, K ;
Mandarino, LJ ;
DeFronzo, RA .
DIABETOLOGIA, 2002, 45 :A234-A234
[37]   Metformin shown to be the most durable first line glucose lowering therapy for people with type 2 diabetes [J].
Idris, Iskandar .
DIABETES OBESITY & METABOLISM, 2015, 17 (01) :102-103
[38]   Rosiglitazone maleate/metformin hydrochloride - A new formulation therapy for type 2 diabetes [J].
Cox, SL .
DRUGS OF TODAY, 2004, 40 (07) :633-643
[39]   Effects of rosiglitazone in combination with metformin on cardiovascular biomarkers in type 2 diabetes subjects with microalbuminuria [J].
Bakris, GL ;
McMorn, SO ;
Weston, WM ;
Huang, C ;
Heise, MA .
CIRCULATION, 2005, 112 (17) :U917-U917
[40]   ORAL GLUCOSE LOWERING WITH LINAGLIPTIN PLUS METFORMIN COMPARED WITH LINAGLIPTIN ALONE AS INITIAL TREATMENT IN ASIAN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES AND MARKED HYPERGLYCEMIA [J].
Ma, R. C. W. ;
Del Prato, S. ;
Gallwitz, B. ;
Lewis-D'Agostino, D. ;
Bailes, Z. ;
Patel, S. ;
Lee, J. S. ;
von Eynatten, M. ;
Ross, S. A. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 :S22-S23
12345